Aller au contenu principal
Accès ouvert déclaré 2026 article

Maternal and neonatal outcomes in pregnant women with severe thrombocytopenia: insights from a retrospective 8-year cohort study in China

0Citations signalées, ce qui n’est pas une note de qualité
9Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objective To characterize the clinical features, maternal outcomes, and neonatal outcomes across different strata of platelet counts in pregnant women with severe thrombocytopenia. Design Retrospective cohort study. Setting A single tertiary care center in South China. Participants 175 pregnant women with a platelet count ≤30 × 10 9 /L. Methods We conducted a retrospective analysis of 175 cases over an 8-year period. Etiologies, maternal characteristics, and maternal-neonatal outcomes were compared across three platelet count strata: ≤10, >10 to ≤20×10 9 /L, and >20 to ≤30×10 9 /L. Statistical analyses included t-tests, the Kruskal-Wallis H test, chi-square tests, and ANOVA. Main Outcome Measures Maternal and neonatal outcomes. Results Primary immune thrombocytopenia (ITP) was the predominant etiology (62.3%, 109/175). The incidence of postpartum hemorrhage was highest in the ≤10×10 9 /L group (12.5%), compared with the >10 to ≤20×10 9 /L (4.8%) and >20 to ≤30×10 9 /L (3.6%) groups. Preterm birth was also most common in the ≤10×10 9 /L group (58.9%), versus the >10 to ≤20×10 9 /L (27.0%) and >20 to ≤30×10 9 /L (23.2%) groups. The rates of neonatal thrombocytopenia were 33.9%, 23.8%, and 14.3% in the three groups, respectively. The overall rate of neonatal intracranial hemorrhage was 3.4% (6/175). Conclusions Primary ITP is the leading cause of severe thrombocytopenia in pregnancy. A lower platelet count, particularly ≤10×10 9 /L, is associated with an increased risk of preterm birth and postpartum hemorrhage. Neonatal intracranial hemorrhage is a rare complication. Severe thrombocytopenia may correlate with preterm delivery but no statistical difference in the incidence of neonatal thrombocytopenia was observed across the maternal platelet strata. Funding : This work was supported by the Guangzhou Fundamental Research Project Jointly Funded by School (Institution) (High-Level University) [No. 202102010131].

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Maternal and neonatal outcomes in pregnant women with severe thrombocytopenia: insights from a retrospective 8-year cohort study in China
Date Crossref
01/08/2026
Éditeur
Elsevier BV
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Platelet Disorders and TreatmentsHeparin-Induced Thrombocytopenia and ThrombosisBlood groups and transfusion

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.